Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Sewell

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of the American Optometric Association|December 1, 1994
New England College of Optometry's impact on Boston neighborhoodsD J Hoffman, R Gross, J M Sewell
Age and Ageing|August 1, 1981
Screening investigations in the elderlyJ M Sewell, L L Spooner, A K Dixon, et al.
British Journal of Cancer|March 5, 2002
Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 ("Iressa")J M Sewell, K G Macleod, A Ritchie, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2005
The mechanism of action of Kahalalide F: variable cell permeability in human hepatoma cell linesJ M Sewell, I Mayer, S P Langdon, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of the American Optometric Association|December 1, 1994
New England College of Optometry's impact on Boston neighborhoodsD J Hoffman, R Gross, J M Sewell
Age and Ageing|August 1, 1981
Screening investigations in the elderlyJ M Sewell, L L Spooner, A K Dixon, et al.
British Journal of Cancer|March 5, 2002
Targeting the EGF receptor in ovarian cancer with the tyrosine kinase inhibitor ZD 1839 ("Iressa")J M Sewell, K G Macleod, A Ritchie, et al.
European Journal of Cancer (Oxford, England : 1990)|June 15, 2005
The mechanism of action of Kahalalide F: variable cell permeability in human hepatoma cell linesJ M Sewell, I Mayer, S P Langdon, et al.
Pageof 1